Crohn’s disease

Adalimumab and Infliximab.

Off

NICE appraisal

TA187 Use of tumour necrosis factor alpha (TNF a) inhibitors (adalimumab, and infliximab [review]) for Crohn’s disease (review of TA40) (May 2010)

DSU reports

DSU response to comments on DSU Crohn’s Report 2 (PDF, 85KB) (August 2009)

Use of tumour necrosis factor alpha (TNF a) inhibitors (adalimumab and infliximab) for Crohn’s Disease – Report 2 (PDF, 372KB) (June 2009)

Use of tumour necrosis factor alpha (TNF a) inhibitors (adalimumab and infliximab) for Crohn’s Disease (PDF, 61KB) (January 2009)